Identification of Alzheimer's disease-associated long noncoding RNAs

Neurobiology of Aging

Volumn 36, Issue 11, 2015, Pages 2925-2931

  Zhou, Xiaolin ^a   Xu, Jie ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Alzheimer's disease; Long noncoding RNA; Microarray

Indexed keywords

BIOLOGICAL MARKER; LONG UNTRANSLATED RNA; CHOLESTEROL; PROTEIN; UNTRANSLATED RNA;

ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; NEUROPATHOLOGY; PRIORITY JOURNAL; RNA ANALYSIS; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION; BRAIN; GENE EXPRESSION; GENETIC ASSOCIATION STUDY; GENETICS; HOMEOSTASIS; METABOLISM; MICROARRAY ANALYSIS;

ALZHEIMER DISEASE; BRAIN; CHOLESTEROL; DOWN-REGULATION; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; HOMEOSTASIS; HUMANS; MICROARRAY ANALYSIS; PROTEINS; RNA, UNTRANSLATED; UBIQUITINATION; UP-REGULATION;

EID: 84947026825     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.07.015     Document Type: Article

References (54)

1. Blennow K., Mattsson N., Scholl M., Hansson O., Zetterberg H. Amyloid biomarkers in Alzheimer's disease. Trends Pharmacol. Sci. 2015, 36:297-309.
2. Braak H., Del Trecidi K. Neuroanatomy and pathology of sporadic Alzheimer's disease. Adv. Anat. Embryol. Cell Biol. 2015, 215:1-162.
3. Bu D., Yu K., Sun S., Xie C., Skogerbo G., Miao R., Xiao H., Liao Q., Luo H., Zhao G., Zhao H., Liu Z., Liu C., Chen R., Zhao Y. NONCODE v3.0: integrative annotation of long noncoding RNAs. Nucleic Acids Res. 2012, 40(Database issue):D210-D215.
4. Calero M., Gomez-Ramos A., Calero O., Soriano E., Avila J., Medina M. Additional mechanisms conferring genetic susceptibility to Alzheimer's disease. Front. Cell. Neurosci. 2015, 9:138.
5. Chance S.A., Clover L., Cousijn H., Currah L., Pettingill R., Esiri M.M. Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease. Cereb. Cortex 2011, 21:1870-1878.
6. Ciacci C., Barmo C., Fabbri R., Canonico B., Gallo G., Canesi L. Immunomodulation in Mytilus galloprovincialis by non-toxic doses of hexavalent chromium. Fish Shellfish Immunol. 2011, 31:1026-1033.
7. Ciarlo E., Massone S., Penna I., Nizzari M., Gigoni A., Dieci G., Russo C., Florio T., Cancedda R., Pagano A. An intronic ncRNA-dependent regulation of SORL1 expression affecting Abeta formation is upregulated in post-mortem Alzheimer's disease brain samples. Dis. Model Mech. 2013, 6:424-433.
8. Shi L., Reid L.H., Jones W.D., Shippy R., Warrington J.A., Baker S.C., Collins P.J., de Longueville F., Kawasaki E.S., Lee K.Y., Luo Y., Sun Y.A., Willey J.C., Setterquist R.A., Fischer G.M., Tong W., Dragan Y.P., Dix D.J., Frueh F.W., Goodsaid F.M., Herman D., Jensen R.V., Johnson C.D., Lobenhofer E.K., Puri R.K., Schrf U., Thierry-Mieg J., Wang C., Wilson M., Wolber P.K., Zhang L., Amur S., Bao W., Barbacioru C.C., Lucas A.B., Bertholet V., Boysen C., Bromley B., Brown D., Brunner A., Canales R., Cao X.M., Cebula T.A., Chen J.J., Cheng J., Chu T.M., Chudin E., Corson J., Corton J.C., Croner L.J., Davies C., Davison T.S., Delenstarr G., Deng X., Dorris D., Eklund A.C., Fan X.H., Fang H., Fulmer-Smentek S., Fuscoe J.C., Gallagher K., Ge W., Guo L., Guo X., Hager J., Haje P.K., Han J., Han T., Harbottle H.C., Harris S.C., Hatchwell E., Hauser C.A., Hester S., Hong H., Hurban P., Jackson S.A., Ji H., Knight C.R., Kuo W.P., LeClerc J.E., Levy S., Li Q.Z., Liu C., Liu Y., Lombardi M.J., Ma Y., Magnuson S.R., Maqsodi B., McDaniel T., Mei N., Myklebost O., Ning B., Novoradovskaya N., Orr M.S., Osborn T.W., Papallo A., Patterson T.A., Perkins R.G., Peters E.H., Peterson R., Philips K.L., Pine P.S., Pusztai L., Qian F., Ren H., Rosen M., Rosenzweig B.A., Samaha R.R., Schena M., Schroth G.P., Shchegrova S., Smith D.D., Staedtler F., Su Z., Sun H., Szallasi Z., Tezak Z., Thierry-Mieg D., Thompson K.L., Tikhonova I., Turpaz Y., Vallanat B., Van C., Walker S.J., Wang S.J., Wang Y., Wolfinger R., Wong A., Wu J., Xiao C., Xie Q., Xu J., Yang W., Zhang L., Zhong S., Zong Y., Slikker W. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 2006, 24:1151-1161. Consortium, M.
9. De Jager P.L., Srivastava G., Lunnon K., Burgess J., Schalkwyk L.C., Yu L., Eaton M.L., Keenan B.T., Ernst J., McCabe C., Tang A., Raj T., Replogle J., Brodeur W., Gabriel S., Chai H.S., Younkin C., Younkin S.G., Zou F., Szyf M., Epstein C.B., Schneider J.A., Bernstein B.E., Meissner A., Ertekin-Taner N., Chibnik L.B., Kellis M., Mill J., Bennett D.A. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat. Neurosci. 2014, 17:1156-1163.
10. DeMattos R.B., Cirrito J.R., Parsadanian M., May P.C., O'Dell M.A., Taylor J.W., Harmony J.A., Aronow B.J., Bales K.R., Paul S.M., Holtzman D.M. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 2004, 41:193-202.
11. Devi L., Prabhu B.M., Galati D.F., Avadhani N.G., Anandatheerthavarada H.K. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci. 2006, 26:9057-9068.
12. De Vrij F.M., Sluijs J.A., Gregori L., Fischer D.F., Hermens W.T., Goldgaber D., Verhaagen J., Van Leeuwen F.W., Hol E.M. Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death. FASEB J. 2001, 15:2680-2688.
13. Du Z., Fei T., Verhaak R.G., Su Z., Zhang Y., Brown M., Chen Y., Liu X.S. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat. Struct. Mol. Biol. 2013, 20:908-913.
14. Faghihi M.A., Modarresi F., Khalil A.M., Wood D.E., Sahagan B.G., Morgan T.E., Finch C.E., St Laurent G., Kenny P.J., Wahlestedt C. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat. Med. 2008, 14:723-730.
15. Gellert P., Ponomareva Y., Braun T., Uchida S. Noncoder: a web interface for exon array-based detection of long non-coding RNAs. Nucleic Acids Res. 2013, 41:e20.
16. Gregori M., Masserini M., Mancini S. Nanomedicine for the treatment of Alzheimer's disease. Nanomedicine 2015, 10:1203-1218.
17. Hannaoui S., Shim S.Y., Cheng Y.C., Corda E., Gilch S. Cholesterol balance in prion diseases and Alzheimer's disease. Viruses 2014, 6:4505-4535.
18. Holden T., Nguyen A., Lin E., Cheung E., Dehipawala S., Ye J., Tremberger G., Lieberman D., Cheung T. Exploratory bioinformatics study of lncRNAs in Alzheimer's disease mRNA sequences with application to drug development. Comput. Math. Methods Med. 2013, 2013:579136.
19. Horesh Y., Katsel P., Haroutunian V., Domany E. Gene expression signature is shared by patients with Alzheimer's disease and schizophrenia at the superior temporal gyrus. Eur. J. Neurol. 2011, 18:410-424.
20. Hu Y., Chen H.Y., Yu C.Y., Xu J., Wang J.L., Qian J., Zhang X., Fang J.Y. A long non-coding RNA signature to improve prognosis prediction of colorectal cancer. Oncotarget 2014, 5:2230-2242.
21. Hu Y., Wang J., Qian J., Kong X., Tang J., Wang Y., Chen H., Hong J., Zou W., Chen Y., Xu J., Fang J.Y. Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. Cancer Res. 2014, 74:6890-6902.
22. Hung T., Chang H.Y. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol. 2010, 7:582-585.
23. Krzywinski M., Schein J., Birol I., Connors J., Gascoyne R., Horsman D., Jones S.J., Marra M.A. Circos: an information aesthetic for comparative genomics. Genome Res. 2009, 19:1639-1645.
24. Lim S.L., Rodriguez-Ortiz C.J., Kitazawa M. Infection, systemic inflammation, and Alzheimer's disease. Microbes Infect. 2015, 17:549-556.
25. Liu C.C., Kanekiyo T., Xu H., Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 2013, 9:106-118.
26. Liu L.H., Xu J., Deng Y.L., Tang H.D., Wang Y., Ren R.J., Xu W., Ma J.F., Wang G., Chen S.D. A complex association of ABCA7 genotypes with sporadic Alzheimer disease in Chinese Han population. Alzheimer Dis. Assoc. Disord. 2014, 28:141-144.
27. Liu T., Huang Y., Chen J., Chi H., Yu Z., Wang J., Chen C. Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1AS expression. Mol. Med. Rep. 2014, 10:1275-1281.
28. Ma Y., Bao J., Zhao X., Shen H., Lv J., Ma S., Zhang X., Li Z., Wang S., Wang Q., Ji J. Activated cyclin-dependent kinase 5 promotes microglial phagocytosis of fibrillar beta-amyloid by up-regulating lipoprotein lipase expression. Mol. Cell Proteomics 2013, 12:2833-2844.
29. Miyazaki M., Miyazaki K., Chen S., Itoi M., Miller M., Lu L.F., Varki N., Chang A.N., Broide D.H., Murre C. Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease. Nat. Immunol. 2014, 15:767-776.
30. Mus E., Hof P.R., Tiedge H. Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10679-10684.
31. Otsubo Y. Use of pharmacogenomics and biomarkers in the development of new drugs for Alzheimer disease in Japan. Clin. Ther 2015, [Epub ahead of print]. 10.1016/j.clinthera.2015.04.010.
32. Patterson T.A., Lobenhofer E.K., Fulmer-Smentek S.B., Collins P.J., Chu T.M., Bao W., Fang H., Kawasaki E.S., Hager J., Tikhonova I.R., Walker S.J., Zhang L., Hurban P., de Longueville F., Fuscoe J.C., Tong W., Shi L., Wolfinger R.D. Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project. Nat. Biotechnol. 2006, 24:1140-1150.
33. Pedersen J.T., Sigurdsson E.M. Tau immunotherapy for Alzheimer's disease. Trends Mol. Med. 2015, 21:394-402.
34. Pelone F., Reeves S., Ioannides A., Emery C., Titmarsh K., Jackson M., Hassenkamp A.M., Greenwood N. Interprofessional education in the care of people diagnosed with dementia: protocol for a systematic review. BMJ Open 2015, 5:e007490.
35. Pensalfini A., Zampagni M., Liguri G., Becatti M., Evangelisti E., Fiorillo C., Bagnoli S., Cellini E., Nacmias B., Sorbi S., Cecchi C. Membrane cholesterol enrichment prevents Abeta-induced oxidative stress in Alzheimer's fibroblasts. Neurobiol. Aging 2011, 32:210-222.
36. Proitsi P., Lupton M.K., Velayudhan L., Newhouse S., Fogh I., Tsolaki M., Daniilidou M., Pritchard M., Kloszewska I., Soininen H., Mecocci P., Vellas B., Williams J., Stewart R., Sham P., Lovestone S., Powell J.F. Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis. PLoS Med. 2014, 11:e1001713. Alzheimer's Disease Neuroimaging, I, Consortium, GConsortium, G.
37. Riederer B.M., Leuba G., Vernay A., Riederer I.M. The role of the ubiquitin proteasome system in Alzheimer's disease. Exp. Biol. Med. 2011, 236:268-276.
38. Ritchie M.E., Phipson B., Wu D., Hu Y., Law C.W., Shi W., Smyth G.K. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015, 43:e47.
39. Shibuya Y., Niu Z., Bryleva E.Y., Harris B.T., Murphy S.R., Kheirollah A., Bowen Z.D., Chang C.C., Chang T.Y. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage. Neurobiol. Aging 2015, 36:2248-2259.
40. Singh P., Cho J., Tsai S.Y., Rivas G.E., Larson G.P., Szabo P.E. Coordinated allele-specific histone acetylation at the differentially methylated regions of imprinted genes. Nucleic Acids Res. 2010, 38:7974-7990.
41. Sun J.H., Yu J.T., Tan L. The role of cholesterol metabolism in Alzheimer's disease. Mol. Neurobiol. 2015, 51:947-965.
42. Tan L., Yu J.T., Hu N., Tan L. Non-coding RNAs in Alzheimer's disease. Mol. Neurobiol. 2013, 47:382-393.
43. Tan M.G., Chua W.T., Esiri M.M., Smith A.D., Vinters H.V., Lai M.K. Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease. J. Neurosci. Res. 2010, 88:1157-1169.
44. Tibshirani R., Hastie T., Narasimhan B., Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6567-6572.
45. Tsai M.C., Manor O., Wan Y., Mosammaparast N., Wang J.K., Lan F., Shi Y., Segal E., Chang H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329:689-693.
46. Tschopp P., Sherratt E., Sanger T.J., Groner A.C., Aspiras A.C., Hu J.K., Pourquie O., Gros J., Tabin C.J. A relative shift in cloacal location repositions external genitalia in amniote evolution. Nature 2014, 516:391-394.
47. Verghese P.B., Castellano J.M., Garai K., Wang Y., Jiang H., Shah A., Bu G., Frieden C., Holtzman D.M. ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E1807-E1816.
48. Wang G., Pan X.L., Cui P.J., Wang Y., Ma J.F., Ren R.J., Deng Y.L., Xu W., Tang H.D., Chen S.D. Association study of the GAB2 gene with the risk of Alzheimer disease in the chinese population. Alzheimer Dis. Assoc. Disord. 2011, 25:283-285.
49. Wang H., Chung P.J., Liu J., Jang I.C., Kean M.J., Xu J., Chua N.H. Genome-wide identification of long noncoding natural antisense transcripts and their responses to light in Arabidopsis. Genome Res. 2014, 24:444-453.
50. Wu P., Zuo X., Deng H., Liu X., Liu L., Ji A. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases. Brain Res. Bull. 2013, 97:69-80.
51. Wu Y., Zhang L., Zhang L., Wang Y., Li H., Ren X., Wei F., Yu W., Liu T., Wang X., Zhou X., Yu J., Hao X. Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma. Int. J. Oncol. 2015, 46:2586-2594.
52. Yu L., Chibnik L.B., Srivastava G.P., Pochet N., Yang J., Xu J., Kozubek J., Obholzer N., Leurgans S.E., Schneider J.A., Meissner A., De Jager P.L., Bennett D.A. Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol. 2015, 72:15-24.
53. Yu X., Zheng J. Cholesterol promotes the interaction of Alzheimer beta-amyloid monomer with lipid bilayer. J. Mol. Biol. 2012, 421:561-571.
54. Zhou X., Xu J. Free cholesterol induces higher beta-sheet content in Abeta peptide oligomers by aromatic interaction with Phe19. PLoS One 2012, 7:e46245.